As per the expanded partnership, which builds on a 20-year relationship, GE Healthcare will use the new Intel Xeon Scalable platform and pair it with GE’s imaging solutions. Additionally, the companies will invest in a new digital development lab in Chicago. The Joint Performance Acceleration Lab will focus on the development, testing and validation of new innovations across GE Healthcare imaging hardware and software solutions.
The companies will also use the Wind River Titanium Control software virtualization platform to fuel new solutions.
“To ensure we are delivering the best possible outcomes at the lowest cost in this digital age, GE Healthcare is partnering with Intel to co-develop on and off premise solutions through our new lab and accelerate these with the Intel Xeon Scalable platform,” said David Hale, senior vice president of enterprise imaging digital solutions at GE Healthcare.
More articles on health IT:
IBM hits quantum computing milestone
AMA, Harvard Health Publishing ‘pause’ partnerships with Outcome Health
NIH taps 14 medical societies, community groups to recruit ‘All of Us’ participants
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
